Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma helps hair regrowth and improves quality of life in women with hair loss, but minoxidil may be more effective.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Alefacept showed some effectiveness for alopecia areata but needs more research.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

Histopathological examination is essential for diagnosing alopecia areata.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

A tick bite caused temporary hair loss in a man, which is a rare condition that usually gets better within 3 months.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

The new skin model can predict how chemicals might cause skin allergies.

Iron deficiency anemia can cause itching, which often improves with iron supplements.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Wound healing is complex and requires more research to enhance treatment methods.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.